CORT
NASDAQ · Pharmaceuticals
Corcept Therapeutics Inc
$108.35
-2.34 (-2.11%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+162.29%
1Y
+51.58%
YTD
+183.64%
Open$111.00
Previous Close$110.69
Day High$111.00
Day Low$107.32
52W High$122.21
52W Low$28.66
Volume—
Avg Volume1.60M
Market Cap12.19B
P/E Ratio257.57
EPS$0.35
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$53.13
Above
SMA 200
$69.00
Above
RSI (14)
26
Oversold
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
12 analysts
Price Target
-5.6% upside
Current
$108.35
$108.35
Target
$102.33
$102.33
$62.31
$102.33 avg
$121.34
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 675.89M | 546.22M | 785.70M |
| Net Income | 88.46M | 64.34M | 178.89M |
| Profit Margin | 13.1% | 12.4% | 22.8% |
| EBITDA | 40.78M | 31.31M | 255.84M |
| Free Cash Flow | — | — | 116.31M |
| Rev Growth | +23.7% | +23.7% | +17.7% |
| Debt/Equity | — | — | 0.15 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,189.35 | +1.67% | 42.6 | 1.08T |
| JNJ | Johnson & Johnson | $257.21 | -0.15% | 29.5 | 621.32B |
| MRK | Merck & Co. Inc. | $128.63 | +0.23% | 36.1 | 322.90B |
| PFE | Pfizer Inc. | $25.98 | +0.64% | 19.1 | 143.06B |
| BMY | Bristol-Myers Squibb Co | $64.09 | +0.72% | 22.3 | 132.99B |
| ZTS | Zoetis Inc | $76.68 | +3.07% | 12.1 | 32.02B |